Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems

• Julia K. Bialek,

  Affiliation Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany

  ⨯
• Gábor A. Dunay,

  Affiliations Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany, German Center for Infection Research (DZIF), partner site, Hamburg, Germany

  ⨯
• Maike Voges,

  Affiliation Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany

  ⨯
• Carola Schäfer,

  Affiliations Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany, German Center for Infection Research (DZIF), partner site, Hamburg, Germany

  ⨯
• Michael Spohn,

  Affiliation Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany

  ⨯
• Rolf Stucka,

  Affiliation Friedrich-Baur-Institute, Department of Neurology, Ludwig Maximilian University Munich, Munich, Germany

  ⨯
• Joachim Hauber,

  Affiliations Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany, German Center for Infection Research (DZIF), partner site, Hamburg, Germany

  ⨯
• Ulrike C. Lange

  * E-mail: ulrike.lange@hpi.uni-hamburg.de

  Affiliations Heinrich Pette Institute – Leibniz Institute for Experimental Virology, Hamburg, Germany, Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, German Center for Infection Research (DZIF), partner site, Hamburg, Germany

  ⨯